Exchange: NSE·Updated 03:29 PM GMT+5:30
News
all
press releases
Aarti Pharmalabs Q4 Print Supports Bullish Technical Trend: SEBI RA Varunkumar Patel
The company reported solid Q4 financials with a 13.2% QoQ rise in EBITDA and 35.2% YoY growth in PAT, driven by strong CDMO/CMO business performance.
Stocktwits

Advertisement|Remove ads.